Antagonists of the angiotensin II type 1 receptor: an approach to control vascular disease beyond blood pressure lowering?
Pauletto
Paolo
P
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D001777:Blood Coagulation / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism; D044140:Receptor, Angiotensin, Type 1; D011945:Receptors, Angiotensin / Q000627:therapeutic use*; D016896:Treatment Outcome; D014652:Vascular Diseases / Q000097:blood / Q000188:drug therapy / Q000517:prevention & control
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D015415:Biomarkers; D044140:Receptor, Angiotensin, Type 1; D011945:Receptors, Angiotensin